Noobie124 Yes, hopefully kanger will make some important announcements soon

https://www.freemalaysiatoday.com/category/world/2021/01/02/contradicting-efficacy-data-for-chinese-covid-vaccine-real-and-valid/

https://www.channelnewsasia.com/news/asia/china-covid-19-sinopharm-vaccine-efficacy-13880548

Noobie123 Most countries will secure doses from multiple vaccines suppliers, not just 1. Sinopharm will just be one of the vaccines those countries will be securing. Besides, Sinopharm is targeting to produce over 1 billion doses by the end of 2021.

Noobie123 That is not entirely true. China's covid situation is mostly under control. Hence, they have sufficient vaccines to supply globally.

China is likely to officially launch a plan for herd immunity in the next half year after the key high risk groups take priority of inoculations first with others being vaccinated later as vaccine production gradually increases.

Beijing city said on Thursday it will inoculate all key groups with the first dose by mid-January and the second dose after two to four weeks. The first to be inoculated include those working in cold storage food facilities, port quarantine, transportation, fresh food markets, medical workers, and those who are going to study or work overseas.

https://www.globaltimes.cn/page/202101/1211565.shtml

https://news.cgtn.com/news/2021-01-02/Answers-for-China-s-first-approved-COVID-19-vaccine--WITUd1oXWo/index.html

Tryluck88 China has repeatedly ensured Malaysia that their vaccines will be heavily subsidized for Malaysia. So do not worry.

Hello is this counter linked to Astra Zeneca vaccine or China vaccine?

Hopefully on Monday, it will be uptrend.

scenery. Help us defend against ularsawa haha

Next Kanger must proceed to appoint a local company to submit the registration application for Sinopharm vaccine to the Ministry of Health. Hopefully it will happen in a timely manner.

Noobie123 Doesnt matter. As long as he can pull political strings it is good enough...He must have played a part in obtaining the MOSTI letter...

It will be interesting to see what happens in the month of January or February

Some internal politics happening. Hopefully Nur Jazlan remains..

Noobie123 I agree Kanger needs to firm up formal distributorship agreement with Sinopharm. Hopefully that will happen in the month of January or February.

Yea can always fall back on bamboo

Yea so hopefully there will be updates from Kanger next month

There doesn't seem to be anything in black and white yet

Noobie123, Go and ask around and i can assure you most people are more concerned with the safety rather than the potential efficacy of covid vaccine. Efficacy wise, Sinopharm pass with flying colours because it is way above the minimum required efficacy threshold of 50% set by US FDA. Safety wise, Sinopharm is the winner as it beats all available covid vaccine due to is inactivated form. Even your regular flu vaccine is inactivated so it is safe.

Noobie123, sinopharm has the edge because inactivated vaccine is the safest with least side effects.

williamtkb even pfizer vaccine has no halal certificate but malaysia ordered it anyway.. So it is not true

williamtkb, actually that is not true. Read this. Besides Sinopharm vaccine is Halal. UAE, Egypt, Morrocco, Bahrain already using Sinopharm vaccine.

https://www.freemalaysiatoday.com/category/nation/2020/12/09/covid-19-vaccine-need-not-be-halal-according-to-health-dg-says-report/

Shouldnt be an issue. Even Pfizer vaccine was given conditional approval by EMA and UK. Likewise Malaysia will also be giving conditional approval for Pfizer vaccine.

Hopefully Kanger will provide further updates next month

There doesn't seem to be any further news regarding GI Healthcare either. All we know at the moment is that they are planning to sponsor 10,000 vaccines for frontliners. No mention about GI healthcare distributing the vaccines. Besides, i wouldn't be too worried as GI Healthcare is not a public listed company and also it is a new joint venture company just set up this year only.

Anyone know the director personally go dig some info haha

I wouldn't speculate yet until the vaccine has been approved in Malaysia

whens the agm

bowman no point announcing until the vaccine has been approved in malaysia right. nothing concrete yet why need to announce...

ularsawa why suddenly talk about lambo here

scenery oh i didnt know that which kind of stocks can short sell?

Just a reminder tomorrow short selling will resume so regardless which stocks you are holding in your portfolio, monitor carefully

https://www.thestar.com.my/business/business-news/2020/12/17/regulated-short-selling-allowed-from-jan-1

China grants conditional market approval for its first homemade COVID-19 vaccine

China on Thursday announced that it has granted market approval attached with conditions for its first homemade COVID-19 vaccine, which was developed by Sinopharm, marking a monumental step in the battle against the pandemic that has killed 1.79 million globally.

The inactivated vaccine developed by Beijing Biological Products Institute under Sinopharm’s subsidiary China National Biotec Group (CNBG), got official authorization from China's National Medical Products Administration on Wednesday，Chen Shifei, deputy head of the National Medical Products Administration, said at Thursday's press conference.

The move came one day after the institute announced that the vaccine showed 79.34 percent efficacy and a 99.52 percent antibody positive conversion rate, according to interim results of the Phase III clinical trials.

The results are better than the 50 percent standard of the World Health Organization (WHO) and Chinese authorities, according to the institute. The vaccine also showed a good safety level, its producers noted.

A vaccine has to undergo strict review by each country's national drug administration before being authorized for public use. All data and processes are reviewed by professional third-party committees, CNBG's chairman Yang Xiaoming told the Global Times in a recent exclusive interview.

Yang was inoculated with a CNBG vaccine in March with hundreds of his colleagues. He said they had tested the level of antibodies six months after vaccination and the results were good.

Yang noted that data on safety and efficacy collected so far in the Phase III clinical trials is better than expected

Reported side effects of the vaccines are also milder than expected, Yang said. The side effects of CNBG's inactivated vaccines include aches or redness at the injection site, fever, muscular soreness, sickness and headache.

A representative of Sinopharm told the Global Times on Wednesday that the interim results are mainly based on data from trials conducted in the United Arab Emirates, the vaccine's largest test base. The Chinese regulator uses a very rigorous standard - stronger even than the international criteria - in reviewing the number of confirmed infected cases in the double-blind placebo-controlled trials for understanding the efficacy of the vaccine.

The Beijing institute's vaccine was approved in the UAE and Bahrain earlier this month.

Sinopharm's two inactivated vaccines have been administered to nearly 1 million people for emergency use and no serious adverse reactions have been reported. About 70,000 volunteers have participated in the phase-III clinical trials in more than 10 countries.

So far, at least 10 provinces in China, including East China's Jiangsu Province and South China's Guangdong Province, have officially announced a vaccination plan for local residents.

To form an immunology barrier it requires at least 700 million Chinese residents to be vaccinated, which means at least 1.4 billion doses, Yang said.

Normally there would only be 500-700 million doses of vaccines available on the Chinese market every year, Yang said, noting that it would be a big challenge for China to conduct mass vaccination in such a short time.

According to Yang, CNBG's production capacity of COVID-19 inactivated vaccines has reached 120 million doses by the end of the year and it will expand to one billion doses per year in 2021.

Yang noted that China has established a complete cold-chain industry for vaccine delivery. The only potential problem may lie in the imbalance between different areas such as developed coastal areas and central and western areas that are comparatively less developed.

Tao Lina, a vaccine expert in Shanghai, said that the approval demonstrated that China has created a "miracle" by creating a vaccine within one year.

Pfizer and Moderna have announced 95 percent efficacy for their mRNA vaccines, which was beyond predictions and drove up the public's expectation for Chinese inactivated vaccines.

Tao noted that despite the high efficacy, the US mRNA vaccines have shown more side effects as well as acute allergy occurrences. The mRNA vaccines also have more strict requirements for transportation.

Tao suggested that the inactivated and mRNA vaccines can both help human beings to resist the novel coronavirus. But both are early-stage products and more improved ones are expected, which will offer more balance between efficacy, safety and transportation requirements.

https://www.globaltimes.cn/page/202012/1211512.shtml

https://www.freemalaysiatoday.com/category/highlight/2020/12/30/us-nurse-tests-positive-after-receiving-pfizer-covid-19-vaccine/

https://www.theedgemarkets.com/article/private-sector-players-look-fill-vaccine-supply-gap

aiyo scary la this pfizer. who dare to be guinea pig?
https://www.foxnews.com/us/pfizer-covid-19-vaccine-allergic-reactions

Another plus point is sinopharm vaccine is halal. Middle eastern countries are already using it. Muslims will favour halal vaccines...Just saying..

Sinopharm vaccine is the safest among all the covid vaccines as it is inactivated. Very minimal and minor side effects which is to be expected of ANY vaccines. Furthermore, it does not require ultracold temperature to store, just regular refrigerator temperature. That is their plus point. Couple that with heavily subsidized vaccine price courtesy of China government. Also remember, foreigners working in malaysia do not have access to free vaccine at government clinic. Hence, they will need to go to private to be vaccinated. Vaccine theme is mainly a game of which vaccine comes first. Whichever vaccine approved and marketed first will have and edge and get a bigger slice of the pie...cansino and sinovac interim results not even announced yet and neither have they been submitted to china fda for approval. Also remember, the new norm is that countries worldwide will implement covid vaccine passport, dont even think of travelling overseas if you are not vaccinated, you will NOT be allowed access to any country without being vaccinated...

no point arguing here we let the market decide...

regardless vaccine euphoria will spill over all vaccine counters...

pfizer vaccine is special as need ultracold temperature. this is something new. other types of vaccines in market only require regular temperature..

no need to build special cold storage facility as no need ultracold storage like pfizer. regular refrigerator will do..

kanger teaming up with expert zuellig pharma for vaccine distribution so no worries...
https://www.thestar.com.my/business/business-news/2020/10/27/kanger-in-mou-with-zuellig

sinopharm only need regular refrigerator to store no big deal unlike pfizer need ultracold temperature

China reassured malaysia and other SEA countries repeatedly that vaccines from china will be heavily subsidized no worries

sinopharm is free from serious side effects..

Its matter of preference. Some ppl will look at efficacy, some will look at price, some will consider whether halal or not. Different ppl got different criteria. No one size fits all...besides read somewhere sinopharm is safest vaccine available as it is inactivated....

sinopharm is halal so most likely muslims will prefer sinopharm

so efficacy rate passed...

ularsawa cannot say like that it is relative. minimum requirement for vaccine efficacy by usfda is 50% read this please.

https://www.nbcnews.com/health/health-news/fda-s-cutoff-covid-19-vaccine-effectiveness-50-percent-what-n1245506